On the recordJune 20, 2019
Madam Chair, I thank the gentleman for his comments and Ranking Member Fortenberry's assurances that we can get together with the FDA and see what we can do to resolve this very difficult issue. I look forward to working with him on this issue going forward. Madam Chair, I yield back the balance of my time and withdraw my amendment. The Acting CHAIR. The amendment is withdrawn. Amendment No. 105 Offered by Mr. Pence The Acting CHAIR. It is now in order to consider amendment No. 105 printed in part B of House Report 116-119.
